Patients with a documented history of drug allergies should inform their prescriber before starting a GLP-1 agonist
These agents work by stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways
Mood changes This includes reports of reduced interest in pleasurable activities, low mood, and in some cases anxiety have been reported
How Should Researchers Store Retatrutide
Timing Baseline Marker Fasting glucose Why it matters Gives a current glucose snapshot, especially when appetite and medication needs change
As GLP1 use rises, new patient volume for hypertension and cholesterol therapies has declined, while GERD treatments remain stable due to GLP1s mixed impact, showing ripple effects across multiple disease areas